Condition: Diabetic Kidney Disease (DKD) · Sponsor: Regeneron Pharmaceuticals
This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidney disease. The aim of the study is to see how safe and effective the study drugs are. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times
This description comes directly from the study's public registry record.
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Always discuss trial participation with your own doctor first.
| Apogee Clinical Research, LLC | Huntsville, Alabama, United States | Recruiting |
| Applied Research Center of Arkansas | Little Rock, Arkansas, United States | Recruiting |
| AME Clinical Research | Huntington Beach, California, United States | Recruiting |
| Amicis Research Center | Northridge, California, United States | Recruiting |
| FOMAT - Vista del Mar Medical Group | Oxnard, California, United States | Recruiting |
| Central Coast Nephrology | Salinas, California, United States | Recruiting |
| North America Research Institute | San Dimas, California, United States | Recruiting |
| Amicis Research Center | Santa Clarita, California, United States | Recruiting |
| Valiance Clinical Research | Tarzana, California, United States | Recruiting |
| Amicis Research Center | Valencia, California, United States | Recruiting |
| National Institute of Clinical Research, Inc. | Victorville, California, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
+ 45 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07271186